ArticleCase reports in oncology

Exceptional Response to Fixed Duration Obinutuzumab and Venetoclax in a Patient with Chronic Lymphocytic Leukemia: A Case Report.

Maya Rosenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.